Internal Medicine, Rheumatology · Santa Rosa, CA
NPI
1144592205
Since 2012
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
401 Bicentennial Way, Dept of Rheumatology Suite 160
Santa Rosa, CA, 95403
Phone (707) 393-4155
Groups this clinician bills Medicare through
Medicare paid, 2024
$6,623
259 services
Medicare patients, 2024
11
Average age 61
Drug cost, 2024
$2.4M
2,498 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Khashayar Khosraviani prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 716 prescriptions and refills. In total Khashayar Khosraviani wrote 2,498 Medicare prescriptions that cost $2.4M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-17.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Methotrexate Methotrexate Sodium | 716 | 2,193 | 262 | $18K |
| Hydroxychloroquine Sulfate Generic | 381 | 1,264 | 137 | $15K |
| Prednisone Generic | 334 | 890 | 147 | $4,344 |
| Leflunomide Generic | 162 | 540 | 69 | $5,868 |
| Amjevita(Cf) Autoinjector Adalimumab-Atto | 150 | 358 | 44 | $348K |
| Enbrel Sureclick Etanercept | 121 | 124 | 15 | $649K |
| Sulfasalazine Generic | 121 | 392 | 56 | $8,559 |
| Orencia Clickject Abatacept | 74 | 77 | Under 11 | $355K |
| Cosentyx Sensoready (2 Pens) Secukinumab | 57 | 57 | Under 11 | $254K |
| Xeljanz Tofacitinib Citrate | 49 | 52 | Under 11 | $135K |
| Enbrel Etanercept | 47 | 50 | Under 11 | $250K |
| Rasuvo Methotrexate/Pf | 37 | 60 | Under 11 | $24K |
| Veo Insulin Syringe Syringe And Needle,insulin,1ml | 32 | 75 | 15 | $224 |
| Leucovorin Calcium Generic | 27 | 84 | 11 | $540 |
| Azathioprine Generic | 25 | 83 | 13 | $1,294 |
Brand drugs: 859 claims; generic drugs: 1,594 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Khashayar Khosraviani were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.